GlassScriptPhysician profile
Brock K Bakewell
NPI 1487791547
$11,952.25
in general payments reported to CMS, 2019-2025
24 companies · $7,427 in 2025
The $7,427 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $663 · 2021: $662 · 2022: $479 · 2023: $1,057 · 2024: $726 · 2025: $7,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,200 · Food and Beverage: $3,393 · Travel and Lodging: $577 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,200.00 |
| Food and Beverage | $3,393.17 |
| Travel and Lodging | $577.37 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $6,680.18 | 2020-2025 | Travoprost Intraocular Implant - Idose, Idosetr, Idose |
| Johnson & Johnson Surgical Vision, INC. | $1,508.09 | 2019-2025 | Veritas Vision System, Tecnis Iol, Tecnis Iol |
| Rxsight INC | $785.51 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $704.04 | 2019-2022 | |
| Alcon Vision LLC | $441.08 | 2020-2023 | Argos |
| Bausch & Lomb Americas INC. | $184.33 | 2022-2025 | Miebo, Prolensa, Vyzulta |
| Mallinckrodt Hospital Products INC. | $167.61 | 2025 | Acthar |
| Sight Sciences, INC. | $159.87 | 2025 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $155.48 | 2019-2021 | |
| Allergan, INC. | $150.96 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.71 | 2021 | |
| Ocular Therapeutix, INC. | $136.10 | 2020-2023 | Dextenza |
| Carl Zeiss Meditec, INC. | $130.76 | 2019 | |
| Abbvie INC. | $128.63 | 2023-2024 | Durysta |
| Johnson & Johnson Vision Care, INC. | $90.89 | 2024 | Veritas Vision System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $90.49 | 2019-2021 | |
| Ivantis, INC | $75.99 | 2019 | |
| Kala Pharmaceuticals, INC. | $62.13 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $44.98 | 2020 | |
| Horizon Therapeutics Plc | $41.36 | 2021 | |
| Harrow Eye, LLC | $23.43 | 2024 | Iheezo, Tobradex St, Flarex |
| Oyster Point Pharma, INC. | $19.68 | 2022 | |
| Abb Con-Cise Optical Group LLC | $15.31 | 2023 | Spectacle Lenses, Contact Lens |
| Shire North American Group INC | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Bakewell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.